FBXO5 and cancer: Moreover, the comparison of FBXO5 expression across different pathological stages of each cancer type was assessed, which indicated that FBXO5 expression was higher in more advanced stages of the four malignancies, namely ACC, KICH, LIHC, and UCEC.